Beijing, China

Qingjuan Yang

This inventor holds 1 USPTO granted patent. Top assignee: Beijing Chenguang Tongchuang Pharmaceutical Research Institute Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingjuan Yang. Retrieved from https://idiyas.com/inventor/qingjuan-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qingjuan Yang: Innovator in Pharmaceutical Research

Introduction

Qingjuan Yang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of prodrug compounds. His innovative work aims to enhance the efficacy and usability of existing medications.

Latest Patents

Yang holds a patent for a prodrug compound of levosimendan, which includes a preparation method and its various uses. This invention addresses the limitations of levosimendan, particularly its poor water solubility. The prodrug compound is designed to improve pharmacokinetic profiles and offers excellent prospects for future medicament development.

Career Highlights

Qingjuan Yang is affiliated with the Beijing Chenguang Tongchuang Pharmaceutical Research Institute Co., Ltd. His work at this institute has been pivotal in advancing pharmaceutical innovations. He has dedicated his career to improving drug formulations and enhancing therapeutic outcomes.

Collaborations

Yang has collaborated with notable colleagues, including Shaolin Huang and Changbin Guo. These partnerships have fostered a collaborative environment that encourages innovative research and development in the pharmaceutical sector.

Conclusion

Qingjuan Yang's contributions to pharmaceutical research, particularly through his patent on levosimendan prodrug compounds, highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medication development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…